The association of diabetes duration and glycemic control with depression in elderly men with type 2 diabetes mellitus

Kim, Hae Jin; An, So Yeon; Han, Seung Jin; Kim, Dae Jung; Hong, Chang Hyung; Kim, Yong Hyun; Shin, Dong Hyun; Kim, Nan Hee; Seo, Ji A; Ahn, Yu‐Bae; Ko, Seung Hyun; Cho, Yong Wook; Park, Seok Won; Kim, Soo‐Kyung; Kim, Kyung Wook; Kim, Chul Sik; Lee, Kwan Woo

doi:10.4103/jrms.jrms_43_18

Cited by 19 publications

(1 citation statement)

References 26 publications

(32 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study enrolled 155 patients (56 men and 99 women) aged ≥ 65 years. The short form of the geriatric depression scale-Korean version (SGDS-K) was used to assess the severity of depression [29]. In our study, the HbA1c levels among the subjects with severe depressive symptoms were ≥ 10% in four (19.0%) patients and ≥ 8% and <10% in 10 (47.6%) patients.…”

Section: Discussionmentioning

confidence: 72%

Prevalence of Depressive Symptoms in the Elderly Population Diagnosed with Type 2 Diabetes Mellitus

Dziedzic

Sienkiewicz

Leńczuk-Gruba

et al. 2020

IJERPH

View full text Add to dashboard Cite

Introduction: A sharp rise in the population of elderly people, who are more prone to somatic and mental diseases, combined with the high prevalence of type 2 diabetes mellitus and diabetes-associated complications in this age group, have an impact on the prevalence of depressive symptoms. Aim of the work: The work of the study was the evaluation of the prevalence of depressive symptoms in the elderly population diagnosed with type 2 diabetes mellitus. Materials and methods: The pilot study was conducted in 2019 among 200 people diagnosed with type 2 diabetes mellitus, aged 65 years and above, receiving treatment in a specialist diabetes outpatient clinic. The study was based on a questionnaire aimed at collecting basic sociodemographic and clinical data and the complete geriatric depression scale (GDS, by Yesavage) consisting of 30 questions. Results: The study involved 200 patients receiving treatment in a diabetes outpatient clinic. The mean age of the study subjects was 71.4 ± 5.0 years. The vast majority of the subjects (122; 61%) were women, with men accounting for 39% of the study population (78 subjects). A statistically significant difference in the GDS (p < 0.01) was shown for marital status, body mass index (BMI), duration of diabetes, and the number of comorbidities. Patients with results indicative of symptoms of mild and severe depression were found to have higher BMI, longer disease duration, and a greater number of comorbidities. There were no statistically significant differences in the level of HbA1c. Conclusions: In order to verify the presence of depressive symptoms in the group of geriatric patients with diabetes mellitus, an appropriate screening programme must be introduced to identify those at risk and refer them to specialists, so that treatment can be promptly initiated. Screening tests conducted by nurses might help with patient identification.

show abstract

Section: Discussionmentioning

confidence: 72%

Prevalence of Depressive Symptoms in the Elderly Population Diagnosed with Type 2 Diabetes Mellitus

Dziedzic

Sienkiewicz

Leńczuk-Gruba

et al. 2020

IJERPH

View full text Add to dashboard Cite

show abstract

Impact of team‐based pharmaceutical care on the humanistic outcomes among patients with long‐standing diabetes: An interim analysis of a randomized, controlled, multicenter study

Gallagher

Tan³

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

IntroductionEpidemiological studies have reported that diabetes‐related complications increase after 5 years of uncontrolled/suboptimal metabolic control. The risk of experiencing diabetes‐related microvascular diseases usually spike after 10 years of uncontrolled diabetes.ObjectivesThe objective of this study was to evaluate the impact of team‐based pharmaceutical care on glycemic control, self‐care, diabetes‐dependent quality of life, and productivity loss in patients with long‐standing diabetes (≥5 years).MethodsThis was a prospective, multicenter, randomized, controlled study. Patients with a glycosylated hemoglobin (HbA1c) > 7%, long‐standing diabetes defined as having a disease duration of at least 5 years, and polypharmacy defined as taking 5 or more chronic medications were included in the study. Patients in the intervention arm received team‐based pharmaceutical care regularly while patients in the control arm received physician‐centered care. Patients' humanistic outcomes were followed for 6 months.ResultsA total of 248 patients (126 intervention and 122 control) were included in the study. In addition to improved glycemic control observed in the intervention arm (mean difference: 0.44%, P = .003, 95% confidence interval: [0.15, 0.73]), the intervention arm showed significant improvements in overall self‐care level (+0.36, 95% confidence interval: [0.01, 0.72], P = .045) and self‐monitoring of blood glucose (+1.87, 95% confidence interval: [1.00, 2.99], P < .001) compared with the control arm. There were no significant differences in the changes in diabetes‐associated quality of life and overall work impairment between the two arms. A significant difference in activity impairment (affected productivity in regular unpaid activity) between the two arms was found, with 43.3% impairment having occurred in the control group vs 27.9% in the intervention group (P = .047).ConclusionTeam‐based pharmaceutical care significantly improved overall self‐care and glycemia without deteriorating quality of life and incurring productivity loss. Our findings highlighted the value of team‐based pharmaceutical care in managing diabetes‐experienced patients.

show abstract

Diabetes mellitus

Kapfhammer¹

2022

Depression, Angst, Traumatischer Stress Und Internistische Erkrankungen

View full text Add to dashboard Cite

The association of diabetes duration and glycemic control with depression in elderly men with type 2 diabetes mellitus

Cited by 19 publications

References 26 publications

Prevalence of Depressive Symptoms in the Elderly Population Diagnosed with Type 2 Diabetes Mellitus

Prevalence of Depressive Symptoms in the Elderly Population Diagnosed with Type 2 Diabetes Mellitus

Impact of team‐based pharmaceutical care on the humanistic outcomes among patients with long‐standing diabetes: An interim analysis of a randomized, controlled, multicenter study

Diabetes mellitus

Contact Info

Product

Resources

About